Cargando…
Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin
Lung cancer accounts for the highest percentage of cancer morbidity and mortality worldwide, and lung adenocarcinoma (LUAD) is the most prevalent subtype. Although numerous therapies have been developed for lung cancer, patient prognosis is limited by tumor metastasis and more effective treatment ta...
Autores principales: | Wang, Yuanyi, Zhang, Ting, Du, Hongfei, Yang, Min, Xie, Guangsu, Liu, Teng, Deng, Shihua, Yuan, Wei, He, Shuang, Wu, Dongming, Xu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360146/ https://www.ncbi.nlm.nih.gov/pubmed/37449493 http://dx.doi.org/10.3892/or.2023.8598 |
Ejemplares similares
-
Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma
por: Zhang, Xiangqian, et al.
Publicado: (2023) -
Catheptic and Dipeptidase Activities of Ascites Tumour Cells
por: Malmgren, H., et al.
Publicado: (1955) -
Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor–induced dipeptidase-1 expression and glutathione depletion
por: von Mässenhausen, Anne, et al.
Publicado: (2022) -
Quercetin alleviates lipopolysaccharide-induced acute lung injury by inhibiting ferroptosis via the Sirt1/Nrf2/Gpx4 pathway
por: Deng, Shihua, et al.
Publicado: (2023) -
The Content of Dipeptidases and Acid Proteinases in the Ascitic Fluid of Mice with Ascites Tumours
por: Sylvén, B., et al.
Publicado: (1959)